These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 41487)

  • 1. Destruction of cytochrome P-450 by 2-isopropyl-4-pentenamide and methyl 2-isopropyl-4-pentenoate: mass spectrometric characterization of prosthetic heme adducts and nonparticipation of epoxide metabolites.
    Ortiz de Montellano PR; Yost GS; Mico BA; Dinizo SE; Correia MA; Kumbara H
    Arch Biochem Biophys; 1979 Oct; 197(2):524-33. PubMed ID: 41487
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of cytochrome P-450 by 2-isopropyl-4-pentenamide and other xenobiotics leads to heme-derived protein adducts.
    Davies HW; Britt SG; Pohl LR
    Chem Biol Interact; 1986 Jun; 58(3):345-52. PubMed ID: 3742647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The allylisopropylacetamide and novonal prosthetic heme adducts.
    Ortiz de Montellano PR; Stearns RA; Langry KC
    Mol Pharmacol; 1984 Mar; 25(2):310-7. PubMed ID: 6700576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous heme restores in vivo functional capacity of hepatic cytochrome P-450 destroyed by allylisopropylacetamide.
    Farrell GC; Schmid R; Kunze KL; Ortiz de Montellano PR
    Biochem Biophys Res Commun; 1979 Jul; 89(2):456-63. PubMed ID: 486175
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect in vivo and in vitro of allylisopropylacetamide on the content of hepatic microsomal cytochrome P-450 2 of phenobarbital treated rabbits.
    Liem HH; Johnson EF; Muller-Eberhard U
    Biochem Biophys Res Commun; 1983 Mar; 111(3):926-32. PubMed ID: 6838593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destruction of endogenous and exogenous haem by 2-allyl-2-isopropylacetamide: role of the liver cytochrome P-450 which is inducible by phenobarbitone.
    Unseld A; de Matteis F
    Int J Biochem; 1978; 9(12):865-9. PubMed ID: 744288
    [No Abstract]   [Full Text] [Related]  

  • 7. Reaction schemes for the degradation of cytochrome P-450 by allyl-iso-propylacetamide and fluroxene.
    Ivanetich KM; Ziman MR; Bradshaw JJ
    Adv Exp Med Biol; 1981; 136 Pt B():1213-20. PubMed ID: 6124093
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for the catalytic activity of endogenous iron in the lipid peroxidative destruction of heme by allylisopropylacetamide in the rat liver.
    Maines MD
    Int J Biochem; 1980; 12(5-6):781-5. PubMed ID: 7450133
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbon tetrachloride and 2-isopropyl-4-pentenamide-induced inactivation of cytochrome P-450 leads to heme-derived protein adducts.
    Davies HW; Britt SG; Pohl LR
    Arch Biochem Biophys; 1986 Jan; 244(1):387-92. PubMed ID: 3947068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiporphyric activity of theophylline in normal and allylisopropylacetaminde-treated rats.
    Pinelli A; Capuano A; Maestri P
    Biochem Pharmacol; 1978; 27(13):1729-30. PubMed ID: 708453
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo effects of the cytochrome P-450 suicide substrate 2-isopropyl-4-pentenamide (allylisopropylacetamide) on the disposition and metabolic pattern of propranolol.
    Silber B; Mico BA; Ortiz de Montellano PR; Dols DM; Riegelman S
    J Pharmacol Exp Ther; 1981 Oct; 219(1):125-33. PubMed ID: 7288600
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiporphyric effect exerted by caffeine administration in allylisopropylacetamide-treated rats.
    Pinelli A; Capuano A; Agliati A
    Pharmacol Res Commun; 1974 Feb; 6(1):91-6. PubMed ID: 4427922
    [No Abstract]   [Full Text] [Related]  

  • 13. Structural and functional reconstitution of hepatic cytochrome P-450 in vivo. Reversal of allylisopropylacetamide-mediated destruction of the hemoprotein by exogenous heme.
    Farrell GC; Correia MA
    J Biol Chem; 1980 Nov; 255(21):10128-33. PubMed ID: 7430117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced porphyrin biosynthesis--XII. Levels of cytochrome P-450 in chick embryo liver following administration of allylisopropylacetamide and propylisopropylacetamide.
    Krupa V; Creighton JC; Freeman M; Marks GS
    Can J Physiol Pharmacol; 1974 Aug; 52(4):891-5. PubMed ID: 4473259
    [No Abstract]   [Full Text] [Related]  

  • 15. Allylisopropylacetamide preferentially interacts with the phenobarbital-inducible form of rat hepatic microsomal P-450.
    Baird MB; Birnbaum LS; Samis HB; Massie HR; Zimmerman JA
    Biochem Pharmacol; 1976 Nov; 25(21):2415-7. PubMed ID: 826256
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of the porphyrogenic agent 2-allyl-2-isopropylacetamide on the hydroxylation of testosterone in rat liver microsomal fraction.
    Hodgins MB; Steyer M; Staib W
    Biochem Soc Trans; 1973 Jul; 1(4):942-4. PubMed ID: 4153341
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of cytochrome P-450 containing haem or cobalt-protoporphyrin in liver homogenates of rats treated with phenobarbital and allylisopropylacetamide.
    Bonkovsky HL; Sinclair JF; Healey JF; Sinclair PR; Smith EL
    Biochem J; 1984 Sep; 222(2):453-62. PubMed ID: 6477526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical effects of the porphyrinogenic drug allylisopropylacetamide. A comparative study with phenobarbital.
    Rao MR; Padmanaban G
    Biochem J; 1973 Aug; 134(4):859-68. PubMed ID: 4357714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction schemes for the degradation of cytochromes P-450 by allyl-isopropylacetamide and fluroxene.
    Ivanetich KM; Ziman MR; Bradshaw JJ
    Biochem Pharmacol; 1980 Oct; 29(20):2805-14. PubMed ID: 6108115
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the porphyrin-inducing activity of ethynyl compounds and conformationally restricted and unrestricted analogues of allylisopropylacetamide in chick embryo liver cell culture.
    Marks GS; Zimmer SB; Dinizo SE; Mico BA; Kunze KL; Ortiz de Montellano PR
    Mol Pharmacol; 1981 Jul; 20(1):206-10. PubMed ID: 7290085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.